drugset / Trial / NCT06465056
Use of Botulinum Toxin A in Direct Eyebrow Lift Scar
Phase 2
Unknown
40 enrolled
University of Sao Paulo
Faculdade de Medicina do ABC · collabUniversity of Campinas, Brazil · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Prospective, controlled and randomized study in which participants indicated for surgery to direct eyebrow lift will be randomized into two groups. In addition to surgery, the patients will be treated with botulinum toxin in one eyebrow and saline (placebo) in the other site. The patients participate as treatment and placebo at the same time. Assessments will be carried out through non-invasive exams.
Timeline
- Start
- 2024-01-01
- Primary completion
- 2025-01-01
- Completion
- 2026-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | — |